Human medicines European public assessment report (EPAR): Herwenda, trastuzumab, Date of authorisation: 15/11/2023, Revision: 2, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 20 October 2025 - 16:40

Human medicines European public assessment report (EPAR): Herwenda, trastuzumab, Date of authorisation: 15/11/2023, Revision: 2, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/herwenda

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters